DOI:
10.1055/s-00000072
Seminars in Reproductive Medicine
LinksClose Window
References
Guirakhoo F, Kitchener S, Morrison D , et al.
Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.
Hum Vaccin 2006;
2 (2) 60-67
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.